Pulmonary Complications of Allografts

N/ACompletedNCT01219972

Assistance Publique - Hôpitaux de Paris245 enrolled

Overview

This is a prognostic study of the late lung complications arising at the patient's having received an allograft of hematopoetic stem cells.

* Objectives To estimate the incidence of late (at least occurring 100 days after transplantation) pulmonary complications following allogeneic blood stem cells transplantation * Study Design Prospective Cohort Study All follow-up data were actualiized in September, 2016. * Sample Size 200 transplanted patients * Main Endpoint Non infectious pulmonary complications within the first 3 years

Study Type

OBSERVATIONAL

Enrollment

245

Conditions

Pulmonary Complications

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Allogeneic Blood stem cell transplantation * Alive at day 100 post-transplant Exclusion Criteria: * Non informed consent

Locations (1)

Hôpital Saint Louis

Paris, Paris, France

Outcomes

Primary Outcomes

Non infectious pulmonary complication

Time frame: 3 years

Secondary Outcomes

Survival after non infectious pulmonary complication

Time frame: 3 years and 10 years

Overall survival

Time frame: 3 years and 10 years

Long term time course of Pulmonary Function Tests (PFTs)

Time frame: 3 years and 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.